InsidersTradesSigma
Track the Kinnate Biopharma Inc. stock price and the full directors' dealings record of the company, a listed equity based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Operating in the Health Care sector, Kinnate Biopharma Inc. has logged 42 public disclosures. The latest transaction was disclosed on 5 April 2024 (Disposition). Among the most active insiders: Krishnamohan Neha. All data is accessible without an account.
42
Insider Decl.
n/a
Thresholds
€12m
9 ops.
Buy Volume
n/a
8 ops.
Sell Volume
43Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 5 April 2024
Declarations42 total
9,671,643 sharesCommon StockSEC:0001104659-24-044187:0
2,186 sharesCommon StockSEC:0001415889-24-010433:0
1,368,339 sharesCommon StockSEC:0000947871-24-000353:0
64,087 sharesCommon StockSEC:0001415889-24-010431:0
1,368,339 sharesCommon StockSEC:0000947871-24-000354:0
27,578 sharesCommon StockSEC:0001415889-24-010424:0
66,377 sharesCommon StockSEC:0001415889-24-010428:0
9,671,643 sharesCommon StockSEC:0001415889-24-010434:0
1,506 shares@ US$2.5910.3% of flowCommon StockSEC:0001415889-24-006755:0
558 shares@ US$2.591.0% of flowCommon StockSEC:0001415889-24-006754:0
558 shares@ US$2.5910.3% of flowCommon StockSEC:0001415889-24-006753:0
1,459 shares@ US$2.258.6% of flowCommon StockSEC:0001209191-23-057455:0
541 shares@ US$2.250.9% of flowCommon StockSEC:0001209191-23-057457:0
541 shares@ US$2.258.6% of flowCommon StockSEC:0001209191-23-057454:0
1,459 shares@ US$2.359.0% of flowCommon StockSEC:0001209191-23-048429:0
541 shares@ US$2.350.9% of flowCommon StockSEC:0001209191-23-048424:0
541 shares@ US$2.359.1% of flowCommon StockSEC:0001209191-23-048426:0
541 shares@ US$4.301.7% of flowCommon StockSEC:0001209191-23-034445:0
541 shares@ US$4.3016.7% of flowCommon StockSEC:0001209191-23-034444:0
1,459 shares@ US$4.3016.7% of flowCommon StockSEC:0001209191-23-034447:0
1,550,956 shares@ US$2.80100.0% of flowCommon StockSEC:0001209191-23-028537:0
Canonical exit: 6 Aug 2023 (T+90)
1,550,956 shares@ US$2.80100.0% of flowCommon StockSEC:0001209191-23-028527:0
Canonical exit: 6 Aug 2023 (T+90)
83,459 shares@ US$2.7511.9% of flowCommon StockSEC:0000947871-23-000540:0
Canonical exit: 2 Aug 2023 (T+90)
83,459 shares@ US$2.7511.9% of flowCommon StockSEC:0000947871-23-000541:0
Canonical exit: 2 Aug 2023 (T+90)
60,998 shares@ US$2.558.1% of flowCommon StockSEC:0000947871-23-000516:0
Canonical exit: 27 Jul 2023 (T+90)
25 of 42 declarations
About Kinnate Biopharma Inc.
Kinnate Biopharma Inc. is a biopharmaceutical company focused on developing targeted therapies for cancer. It employs innovative approaches to identify and develop drugs that address unmet medical needs.